BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.44% | 13.44% | 1.32% | 1.32% | 34.16% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -130.03% | -130.03% | -237.69% | -237.69% | -119.64% |
| Change in Net Operating Assets | -40.35% | -40.35% | -11.54% | -11.54% | -40.02% |
| Cash from Operations | -10.78% | -10.78% | -29.15% | -29.15% | -30.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 748,500.00% | 748,500.00% | 79.15% | 79.15% | -200.00% |
| Cash from Investing | 748,500.00% | 748,500.00% | 79.15% | 79.15% | -200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 99.69% | 99.69% | 33.21% | 33.21% | -941.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -143.74% | -143.74% | 56.43% | 56.43% | 28.87% |
| Other Financing Activities | 66.42% | 66.42% | 11.27% | 11.27% | -5,044,900.00% |
| Cash from Financing | 40.96% | 40.96% | 43.08% | 43.08% | -274.27% |
| Foreign Exchange rate Adjustments | 700.00% | 700.00% | -- | -- | 71.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 126.27% | 126.27% | 98.66% | 98.66% | -146.93% |